Familial dysfibrinogenemia: genes and variants
Explore variant evidence for Familial dysfibrinogenemia across 3 analyzed proteins (FGG, FGA, FGB). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 55 variants of uncertain significance and 12 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial dysfibrinogenemia
FGG: Fibrinogen gamma chain
It contributes the gamma chains of fibrinogen and provides binding sites important for fibrin polymerization, platelet interactions, and clot stabilization. Pathogenic variants can cause quantitative or qualitative fibrinogen disorders and, in some alleles, hereditary renal amyloidosis.
9 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in FGG have source records linked to Familial dysfibrinogenemia. Association strength is not clinical gene validity.
FGA: Fibrinogen alpha chain
It contributes the alpha chains of fibrinogen, which thrombin converts into fibrin to form the structural mesh of blood clots. Pathogenic variants can cause afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, thrombosis, or certain hereditary amyloidoses.
3 ClinVar pathogenic / likely pathogenic and 52 uncertain variants in FGA have source records linked to Familial dysfibrinogenemia. Association strength is not clinical gene validity.
FGB: Fibrinogen beta chain
It contributes the beta chains required for assembly and secretion of functional fibrinogen and subsequent fibrin-clot formation. Pathogenic variants can reduce fibrinogen quantity or alter clot properties, producing bleeding, thrombosis, or both.
2 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in FGB have source records linked to Familial dysfibrinogenemia. Association strength is not clinical gene validity.
Where Familial dysfibrinogenemia variants cluster
- FGG Fibrinogen C-terminal (positions 170–416): 8 of 8 ClinVar pathogenic / likely pathogenic variants, 1.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Familial dysfibrinogenemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGG R301C | 301 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGG R301H | 301 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGG R301S | 301 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGG M336T | 336 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGB R44C | 44 | Pathogenic / likely pathogenic (★★) | |
| FGG R401W | 401 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGA R35C | 35 | Pathogenic / likely pathogenic (★★) | |
| FGA R573C | 573 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| FGA E545V | 545 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| FGG M336L | 336 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★) |
| FGG D344H | 344 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★) |
| FGG D346G | 346 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★) |
| FGB C227R | 227 | Pathogenic / likely pathogenic | |
| FGG D356G | 356 | Fibrinogen C-terminal | Pathogenic / likely pathogenic |
Which prediction tools work for Familial dysfibrinogenemia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 96 out of 100
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 95 out of 100
- MetaLR: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 95 out of 100
- ESM1b (LLR): 87 out of 100
- SpliceAI: 66 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 36 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Afibrinogenemia also has ClinVar records linked to FGB variants; they fall mostly in different places as the Familial dysfibrinogenemia variants (5 pathogenic / likely pathogenic).
Diseases related to Familial dysfibrinogenemia
- Hypertrophic cardiomyopathy, also linked to FGA, FGB and FGG
- Noonan syndrome, also linked to FGA, FGB and FGG
- Costello syndrome, also linked to FGA, FGB and FGG
- Afibrinogenemia, also linked to FGA, FGB and FGG
- Hereditary spastic paraplegia, also linked to FGG
- Deep venous thrombosis, also linked to FGA
- Familial visceral amyloidosis, Ostertag, also linked to FGA
Frequently asked questions
Which genes have records linked to Familial dysfibrinogenemia?
This view contains 3 analyzed proteins: FGG, FGA, FGB. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 55 variants of uncertain significance and 12 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 104 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center